cholestane-3,5,6-triol has been researched along with 8-bromo cyclic adenosine monophosphate in 1 studies
| Studies (cholestane-3,5,6-triol) | Trials (cholestane-3,5,6-triol) | Recent Studies (post-2010) (cholestane-3,5,6-triol) | Studies (8-bromo cyclic adenosine monophosphate) | Trials (8-bromo cyclic adenosine monophosphate) | Recent Studies (post-2010) (8-bromo cyclic adenosine monophosphate) |
|---|---|---|---|---|---|
| 83 | 0 | 20 | 3,707 | 5 | 198 |
| Protein | Taxonomy | cholestane-3,5,6-triol (IC50) | 8-bromo cyclic adenosine monophosphate (IC50) |
|---|---|---|---|
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | 7.7 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | 7.7 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Homo sapiens (human) | 7.7 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 7.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonov, AS; Kabaeva, NV; Perov, NA; Petrova, LE | 1 |
1 other study(ies) available for cholestane-3,5,6-triol and 8-bromo cyclic adenosine monophosphate
| Article | Year |
|---|---|
[Damage to human endothelial cells by cholestane-3 beta,5 alpha,6 beta-triol and the protective effects of preparations that raise the intracellular level of cAMP].
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Adult; Aorta, Thoracic; Arteriosclerosis; Cell Survival; Cells, Cultured; Cholestanols; Colforsin; Cyclic AMP; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Interactions; Endothelium, Vascular; Humans; Middle Aged; Time Factors | 1992 |